AEON Biopharma, Inc. - CL A (AEON)

Q1 2024 13F Holders as of 3/31/2024

Type / Class
Equity / CL A
Number of holders
25
Total Shares
9.47M
Shares change
+805K
Total reported value, excl. options
$103M
Value change
+$9.34M
Put/Call ratio
0
Number of buys
17
Number of sells
-4
Price
$11.60
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.